Ms JENNIFER HISLOP
Research Fellow
work
+44 (0)1224 438084
work
fax
+44 (0)1224 554580
pref
j.hislop@abdn.ac.uk
Research Fellow
M.A. (Hons), BSc (Hons), MSc
|
|
Personal Details
|
||||||||
Jump to:
Biography
Jenni joined the Unit in January 2008, as a Research Fellow for the Systematic Reviews Team. She originally graduated with an M.A. (Hons) in History at the University of Edinburgh in 2001, and then worked as Health Researcher to the Scottish National Party at the Scottish Parliament for three years, before undertaking the MSc in Health Services and Public Health (Health Economics) at the University of Aberdeen. Upon graduating in 2006, she worked as a Project Officer for NHS Education for Scotland (NES) in Dundee for over a year, before joining the Unit.
She has been involved in several systematic reviews for the Unit, on a variety of clinical areas including non-surgical interventions for stress urinary incontinence, the diagnostic accuracy of point-of-care testing for genital chlamydia infection, dose escalation of imatinib (Glivec®) for unresectable and/or metastatic gastrointestinal stromal tumours (GIST), and the use of pazonanib (Votrient™) for the first-line treatment of metastatic renal cell carcinoma.
She is currently working on an MRC-funded project on methods used to specify the targeted difference in randomised controlled trials.
^ top
Research Interests
Systematic Reviews, Health Technology Assessment, Health Economics and Health Policy
^ top
Current Research
Systematic review on methods to specify the targeted difference in randomised controlled trials.
^ top
Teaching Responsibilities
Jenni currently lectures on the Health Services Research course for the MSc in Health Services and Public Health Research, and on the undergraduate Foundations of Health course for the BSc in Health Sciences.
^ top
Publications
Contributions to Journals
Articles
- Hislop, J., Quayyum, Z., Elders, A., Fraser, C., Jenkinson, D., Mowatt, G., Sharma, P., Vale, L. & Petty, R. (2011). 'Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: a systematic review and economic evaluation'. Health Technology Assessment, vol 15, no. 25, pp. 1-178.
[Online] DOI: 10.3310/hta15250
[Online] AURA: Hislop_2011.pdf - Hislop, JM., Mowatt, G., Sharma, P., Fraser, CM., Elders, AS., Jenkinson, DJ., Vale, L. & Petty, RD. (in press). 'Systematic Review of Escalated Imatinib Doses Compared with Sunitinib or Best Supportive Care, for the Treatment of People with Unresectable/Metastatic Gastrointestinal Stromal Tumours Whose Disease has Progressed on the Standard Imatinib Dose'. Journal of Gastrointestinal CAncer.
[Online] DOI: 10.1007/s12029-011-9325-6 - Imamura, M., Abrams, P., Bain, C., Buckley, B., Cardozo, L., Cody, DJ., Cook, JA., Eustice, S., Glazener, CMA., Grant, AM., Hay-Smith, EJC., Hislop, JM., Jenkinson, DJ., Kilonzo, MM., Nabi, G., N'Dow, JM.O, Pickard, R., Ternent, L., Wallace, SA., Wardle, J., Zhu, S. & Vale, LD. (2010). 'Systematic review and economic modelling of the effectiveness and efficiency of non-surgical treatments for women with stress urinary incontinence'. Health Technology Assessment, vol 14, no. 40.
[Online] DOI: 10.3310/hta14400
[Online] AURA: Imamura 2010.pdf - Hislop, JM., Quayyum, Z., Flett, G., Boachie, C., Fraser, CM. & Mowatt, G. (2010). 'Systematic review of the clinical effectiveness and cost-effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men'. Health Technology Assessment, vol 14, no. 29.
[Online] DOI: 10.3310/hta14290
[Online] AURA: Hislop_2010.pdf
Books and Reports
Commissioned Reports
- Imamura, M., Abrams, P., Bain, C., Buckley, B., Cardozo, L., Cody, DJ., Cook, GJ., Eustice, S., Glazener, CMA., Grant, AM., Hay-Smith, J., Hislop, JM., Jenkinson, DJ., Kilonzo, MM., Nabi, G., N'Dow, JM.O, Pickard, R., Ternent, L., Wallace, SA., Wardle, J., Zhu, S. & Vale, LD. (2009). 'Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence'. NIHR Health Technology Assessment programme, Southampton, United Kingdom.
^ top
‹ back